中文    ENGLISH
 
点击这里给我发消息 在线客服
Products Category
 Intermediates of API
 Functional Chemicals
Products
Contact Us

Address: Suite 6, No. 888 Huide Rod, Jiading district, Shanghai 201806, P. R. China
Tel: +86 21 5997 1736
Fax: +86 21 6076 7136
E-mail:info@special-pharma.com
Web:www.special-pharma.com

News
New Molecular Entity and New Therapeutic Biological Product Approvals for 2016  [2016-12-14]
this site hacked by sir shahroukh  [2016-10-18]
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol has been developed by Specpharms as a key intermediate for NK-1 receptor antagonist  [2016-01-19]
New Molecular Entity and New Therapeutic Biological Product Approvals for 2015 (45 totally)  [2015-12-29]
New Molecular Entity and New Therapeutic Biological Product Approvals for 2015  [2015-10-16]
Dolutegravir (Tivicay)  [2015-10-13]
"Science"-Conversion of alcohols to enantiopure amines through dual-enzyme hydrogen-borrowing cascades  [2015-10-09]
Top 10 drugs in 2014 sales  [2015-10-09]
Category:Enzymes  [2015-09-18]
R/S-3-Hydroxyl-N-BocPiperidine were commercially available  [2015-09-17]
Key intermediates of Duloxetine have been developed by Specpharms  [2015-09-16]
第一页 1 最后页 

 



Copyright 2015 Specpharms Scientific Research Limited. All rights reserved. Supported by www.hxchem.net
Address: Suite 6, No. 888 Huide Rod, Jiading district, Shanghai 201806, P. R. China; Tel: +86 21 5997 1736 Fax: +86 21 6076 7136 E-mail: info@special-pharma.com